COVID-19 Vaccine

Updated 6/24/22
The CDC has cleared the way for the youngest kids to receive the COVID vaccination. The agency approved both Pfizer and Moderna vaccine brands. The Pfizer series is a three-dose regimen and the Moderna regimen is two doses. Pfizer is approved for kids 6 months to 4-years-old and Moderna for kids 6 months to 5-years-old. Children 5 and older have been eligible to receive the Pfizer vaccine since November 2021.

NCH recommends vaccinating children to protect them and those they interact with and encourages accessing the vaccine with a community provider that is most convenient for you.

NCH will begin scheduling appointments for ages 6 months to 4 years for Pfizer vaccines only on Monday, June 27.

If you have a MyChart account, login at nch.org/mychart and select a date, time and location to schedule your booster dose.

Make an appointment directly on our website here.

Call 847-618-0242 to schedule an appointment.

COVID-19 Booster Guidance

Eligible For	If you Received Pfizer-BioNTech	If you Received Moderna	If you Received J&J
Additional Primary Shot (for those moderate to severely immunocompromised)	People age 5+ who are moderately or severely immunocompromised should get an additional primary shot of Pfizer-BioNTech COVID-19 vaccine Given 28 days after 2nd shot	People age 18+ who are moderately or severely immunocompromised should get an additional primary shot of Moderna COVID-19 vaccine Given 28 days after 2nd shot	No additional primary shot is recommended at this time
1st Booster Shot	Teens ages 12–17 should only get a Pfizer-BioNTech COVID-19 vaccine booster shot People age 18+ should get a booster shot of either Pfizer-BioNTech or Moderna (mRNA COVID-19 vaccines) in most situations Given at least 5 months after completing the primary series	People age 18+ should get a booster shot of either Pfizer-BioNTech or Moderna (mRNA COVID-19 vaccines) in most situations Given at least 5 months after an additional primary shot	People age 18+ should get a booster shot of either Pfizer-BioNTech or Moderna (mRNA COVID-19 vaccines) in most situations Given at least 2 months after the initial J&J vaccine.
2nd Booster Shot	People age 50+ should get a 2nd booster shot of either Pfizer-BioNTech or Moderna (mRNA COVID-19 vaccines) in most situations. People age 12+ who are moderately or severely immunocompromised should get a 2nd booster shot of only Pfizer-BioNTech in most situations. Given at least 4 months after 1st booster shot	People age 18-49 who are moderately or severely immunocompromised should get a 2nd booster shot of either Pfizer-BioNTech or Moderna (mRNA COVID-19 vaccines) in most situations Given at least 4 months after 1st booster shot	People age 50+ should get a 2nd booster shot of either Pfizer-BioNTech or Moderna (mRNA COVID-19 vaccines) in most situations, given at least 4 months after 1st booster shot People age 18-49 who are moderately or severely immunocompromised should get a 2nd booster shot of either Pfizer-BioNTech or Moderna (mRNA COVID-19 vaccines) in most situations Given at least 4 months after 1st booster shot People ages 18 through 49 years who got a J&J/Janssen COVID-19 vaccine for BOTH their primary dose and 1st booster** can choose to get a 2nd booster of either Pfizer-BioNTech or Moderna COVID-19 vaccine at least 4 months after their 1st booster. This booster is not required to be considered up to date

NCH Hospital Campus, Employee Health
Monday: 8am-4pm Pfizer only
Tuesday-Friday: 8am-4 pm Moderna only
Ages 18 and older

Buffalo Grove ICC
Tuesday & Thursday: 9am-5 pm Pfizer
Ages 5 years and older

Kildeer ICC
Monday & Wednesday: 9am-5pm Pfizer
Ages 5 years and older

Schaumburg ICC
Friday: 9am-5pm Pfizer
Sat/Sun: 8:30am-12pm Pfizer
Ages 5 years and older

Mount Prospect ICC
Wednesday: 12-4pm Pfizer
Ages 5 years and older

A parent or legal guardian must accompany anyone under 18 years of age.

Updated Vaccine Guidance for Immunocompromised Patients

Updated CDC guidance recommends an additional primary dose (3rd dose) to immunocompromised children aged 5-11 years-old 28 days after their primary vaccination series. It has approved a booster (4th dose) for all patients 12 and up 5 months after their 3rd dose.

Patients who are immunocompromised should call the NCH Vaccine Hotline at 847-618-0242 to schedule an appointment.

Immunocompromised patients include those who are:

In active treatment for solid tumor and hematologic malignancies
In receipt of solid-organ transplant and taking immunosuppressive therapy
In receipt of CAR-T-cell or hematopoietic stem cell transplant (within 2 years of transplantation or taking immunosuppression therapy)
Have moderate or severe primary immunodeficiency (e.g., DiGeorge syndrome, Wiskott-Aldrich syndrome)
Advanced or untreated HIV infection
In active treatment with high-dose corticosteroids (i.e., ≥20mg prednisone or equivalent per day), alkylating agents, antimetabolites, transplant-related immunosuppressive drugs, cancer chemotherapeutic agents classified as severely immunosuppressive, tumor-necrosis (TNF) blockers and other biologic agents that are immunosuppressive or immunomodulatory.

COVID-19 AND MONKEYPOX UPDATES

COVID-19 Vaccine

COVID-19 Booster Guidance

Updated Vaccine Guidance for Immunocompromised Patients

Stay safe.

Get NCH Updates via Email